Givaudan takes equity stake in microencapsulation specialist Microcaps
The fragrance and beauty giant is investing in Swiss technology firm Microcaps to strengthen its ingredient delivery capabilities, part of a wider push by flavour and fragrance houses to control the science behind scent longevity.
Givaudan has announced a strategic collaboration and an equity stake in Microcaps AG, a Geneva-area microencapsulation specialist, according to FashionNetwork. The deal is designed to strengthen the fragrance and beauty group's technological capabilities, giving it closer access to encapsulation techniques that control how scent and active ingredients are released in products over time.
Microencapsulation technology has become a competitive battleground in fine fragrance and personal care, since it directly affects how long a perfume lasts on skin or how effectively an active ingredient performs in a cream or detergent. By taking a stake rather than simply licensing the technology, Givaudan secures more direct influence over Microcaps' development roadmap and, presumably, some priority access to its innovations ahead of rivals such as Firmenich-DSM and IFF.
The investment continues a trend among the world's largest fragrance and flavour houses of buying into specialist technology suppliers rather than building every capability in-house, a faster route to innovation in a market where luxury and mass beauty brands alike are demanding differentiated, longer-lasting formulations. What to watch is whether Givaudan moves to full ownership of Microcaps over time, and how quickly the encapsulation technology surfaces in fragrances from its major luxury clients.
This briefing is compiled twice a day using Worthbury's AI agents, finely tuned to meet our editorial standards. While we test and review their work, mistakes can sometimes happen. See exactly how it works.